Constance Lamy
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Ultrasensitive circulating tumor DNA detection improves prognostication in triple-negative breast cancer postneoadjuvant therapy.
Journal: ESMO open
Published: December 10, 2025
SCANDARE: an institutional dynamic prospective interventional biobanking study.
Journal: BMC cancer
Published: November 10, 2025
Constitutional BRCA1 Methylation is associated with high level of tumoral BRCA1 methylation and homologous recombination deficiency in triple-negative breast cancer.
Journal: NPJ breast cancer
Published: November 03, 2025
A clustering-stratified cross-validation framework for validating omics survival models: application to head and neck cancer.
Journal: BMC medical research methodology
Published: July 16, 2025
CMV seropositivity associates with poor clinical outcome in triple negative breast cancer.
Journal: iScience
Published: April 18, 2025
Internal validation strategy for high dimensional prognosis model: A simulation study and application to transcriptomic in head and neck tumors.
Journal: Computational and structural biotechnology journal
Published: April 09, 2025
An Extracellular Matrix-Producing Subset of Cancer-Associated Fibroblasts Drives Chemoresistance in Breast Cancer via SRC Activation and G0S2 Upregulation.
Journal: Cancer research
Published: March 04, 2025
Noninvasive Multicancer Detection Using DNA Hypomethylation of LINE-1 Retrotransposons.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 16, 2024
Methylation, Gene Expression, and Risk Genotypes at the TERT-CLPTM1L Locus in Cervical Cancer.
Journal: Molecular carcinogenesis
Published: May 22, 2024
Deciphering molecular relapse and intra-tumor heterogeneity in non-metastatic resectable head and neck squamous cell carcinoma using circulating tumor DNA.
Journal: Oral oncology
Published: March 19, 2024
Copy number alterations in metastatic and early breast tumours: prognostic and acquired biomarkers of resistance to CDK4/6 inhibitors.
Journal: British journal of cancer
Published: February 21, 2024
Last Updated: 09/26/2026